References 1. Friedman S, Blumberg, RS (2001) Harrison’s Principles of Internal Medicine. New York: McGraw-Hill. pp 1679–1692. 2. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577–594. 3. Dharmani P, Chadee K (2008) Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 1: 195–212. 4. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G (2009) Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 15: 100–113. 5. Thelen M (2001) Dancing to the tune of chemokines. Nat Immunol 2: 129–134. 6. Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, et al. (2008) The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84: 1213–1221. 7. Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, et al. (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82: 1239–1246. 8. Wallace JL, McKnight W, Asfaha S, Liu DY (1998) Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol 274: G802–808. 9. Barreiro O, Martin P, Gonzalez-Amaro R, Sanchez-Madrid F (2010) Molecular cues guiding inflammatory responses. Cardiovasc Res 86: 174–182. 10. Vestweber D (1992) Selectins: cell surface lectins which mediate the binding of leukocytes to endothelial cells. Semin Cell Biol 3: 211–220. 11. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, et al. (1991) Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 77: 2553–2555. 12. Nolte D, Schmid P, Jager U, Botzlar A, Roesken F, et al. (1994) Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L- selectin. Am J Physiol 267: H1637–1642. 13. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25. 14. Chavakis T, Kanse SM, May AE, Preissner KT (2002) Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Biochem Soc Trans 30: 168–173. 15. Springer TA (1995) Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827–872. 16. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678–689. 17. Betancur-Galvis LA, Morales GE, Forero JE, Roldan J (2002) Cytotoxic and antiviral activities of Colombian medicinal plant extracts of the Euphorbia genus. Mem Inst Oswaldo Cruz 97: 541–546. 18. Hecker E (1968) Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res 28: 2338–2349. 19. Rahuman AA, Gopalakrishnan G, Venkatesan P, Geetha K (2008) Larvicidal activity of some Euphorbiaceae plant extracts against Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae). Parasitol Res 102: 867–873. 20. Kumar A, Prasad M, Mishra D, Srivastav SK, Srivastav AK (2010) Toxicity of aqueous extract of Euphorbia tirucalli latex on catfish, Heteropneustes fossilis. Ecotoxicol Environ Saf 73: 1671–1673. 21. Bani S, Kaul A, Khan B, Gupta VK, Satti NK, et al. (2007) Anti-arthritic activity of a biopolymeric fraction from Euphorbia tirucalli. J Ethnopharmacol 110: 92–98. 22. Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, et al. (1999) Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig Dis Sci 44: 1458–1475. 23. Ferretti M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, et al. (1994) Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 94: 449–453. 24. Yue G, Lai PS, Yin K, Sun FF, Nagele RG, et al. (2001) Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite produc- tion. J Pharmacol Exp Ther 297: 915–925. 25. Wang X, Klein RD (2007) Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol Carcinog 46: 912–923. 26. Danese S, Sans M, de la Motte C, Graziani C, West G, et al. (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130: 2060–2073. 27. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, et al. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715. 28. Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, et al. (2009) Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br J Pharmacol 157: 1034–1044. 29. Arulampalam V, Pettersson S (2002) Uncoupling the p38 MAPK kinase in IBD: a double edged sword? Gut 50: 446–447. 30. Papadakis KA, Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51: 289–298. Euphol and Experimental Colitis 31. Hanauer SB, Present DH (2003) The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 3: 81–92. 32. Ardizzone S, Bianchi Porro G (2005) Biologic therapy for inflammatory bowel disease. Drugs 65: 2253–2286. 33. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12 Suppl 1: S3–9. 34. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417–429. 35. Baert F, Vermeire S, Noman M, Van Assche G, D’Haens G, et al. (2004) Management of ulcerative colitis and Crohn’s disease. Acta Clin Belg 59: 304–314. 36. Cuzzocrea S (2003) Emerging biotherapies for inflammatory bowel disease. Expert Opin Emerg Drugs 8: 339–347. 37. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641–1657. 38. Kang SY, Yoon SY, Roh DH, Jeon MJ, Seo HS, et al. (2008) The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant- induced chronic arthritis models. J Pharm Pharmacol 60: 1347–1354. 39. Liu M, Dai Y, Yao X, Li Y, Luo Y, et al. (2008) Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice. Int Immuno- pharmacol 8: 1561–1566. 40. Ma X, Jiang Y, Wu A, Chen X, Pi R, et al. (2010) Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. PLoS One 5: e13489. 41. Martin R, Carvalho-Tavares J, Hernandez M, Arnes M, Ruiz-Gutierrez V, et al. (2010) Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Biochem Pharmacol 79: 198–208. 42. De Paula ML, Rodrigues DH, Teixeira HC, Barsante MM, Souza MA, et al. (2008) Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis. Int Immunophar- macol 8: 1291–1297. 43. Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, et al. (2007) Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Invest 67: 810–820. 44. Cross RK, Wilson KT (2003) Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9: 179–189. 45. Hokari R, Kato S, Matsuzaki K, Kuroki M, Iwai A, et al. (2001) Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 31: 153–163. 46. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, et al. (2001) Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 194: 1207–1218. 47. Sandor Z, Deng XM, Khomenko T, Tarnawski AS, Szabo S (2006) Altered angiogenic balance in ulcerative colitis: a key to impaired healing? Biochem Biophys Res Commun 350: 147–150. 48. Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA (2008) Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 40: 673–679. 49. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E (2002) Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium- induced colitis in rats. Dig Dis Sci 47: 1447–1457. 50. Spehlmann ME, Eckmann L (2009) Nuclear factor-kappa B in intestinal protection and destruction. Curr Opin Gastroenterol 25: 92–99. 51. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221–227. 52. Sanders WE, Wilson RW, Ballantyne CM, Beaudet AL (1992) Molecular cloning and analysis of in vivo expression of murine P-selectin. Blood 80: 795–800. 53. Weller A, Isenmann S, Vestweber D (1992) Cloning of the mouse endothelial selectins. Expression of both E- and P-selectin is inducible by tumor necrosis factor alpha. J Biol Chem 267: 15176–15183. 54. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, et al. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. Faseb J 9: 899–909. 55. Yao L, Pan J, Setiadi H, Patel KD, McEver RP (1996) Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184: 81–92. 56. Stocker CJ, Sugars KL, Harari OA, Landis RC, Morley BJ, et al. (2000) TNF- alpha, IL-4, and IFN-gamma regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells. J Immunol 164: 3309–3315. 57. Kansas GS (1996) Selectins and their ligands: current concepts and controversies. Blood 88: 3259–3287. 58. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD (1993) Leukocyte rolling and extravasation are severely compromised in P selectin- deficient mice. Cell 74: 541–554. 59. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD (1996) Double knockout highlights value of endothelial selectins. Immunol Today 17: 205. 60. Zarbock A, Lowell CA, Ley K (2007) Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 26: 773–783. PLoS ONE | www.plosone.org 14 November 2011 | Volume 6 | Issue 11 | e27122